TCL Archive Cooperative Groups Should Be Trimmed, Brought Under Control Of DCT, Surgical Panel Suggests May 31, 1974
TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment February 2, 1996
TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
